ROS-Responsive Nanoparticles in Breast Cancer: Therapeutic Redox Manipulation and Toxicological Challenges
Current Opinion in Toxicology · 2026-11 · 100629
DOI: 10.1016/j.cotox.2026.100629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Opinion in Toxicology, 2026-11. Verfasst von Sarmad S. Abdullah und 9 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdullah, S. S., Khaleel, Z. T., Esanmuradova, N., Nematov, O., BAIG, M. R., Smerat, A., Hussein, N. A. M., Almegren, A., Zubair, M., & Jabir, M. S. (2026). ROS-Responsive Nanoparticles in Breast Cancer: Therapeutic Redox Manipulation and Toxicological Challenges. Current Opinion in Toxicology, 100629. https://doi.org/10.1016/j.cotox.2026.100629
Vancouver
Abdullah SS, Khaleel ZT, Esanmuradova N, Nematov O, BAIG MR, Smerat A, et al. ROS-Responsive Nanoparticles in Breast Cancer: Therapeutic Redox Manipulation and Toxicological Challenges. Current Opinion in Toxicology. 2026:100629. doi:10.1016/j.cotox.2026.100629
BibTeX
@article{Abdullah2026,
author = {Abdullah, Sarmad S. and Khaleel, Zeina T. and Esanmuradova, Nilufar and Nematov, Ozodbek and BAIG, MIRZA R. and Smerat, Aseel and Hussein, Nouran Abdelhalim Mohamed and Almegren, Afnan and Zubair, Mohammad and Jabir, Majid S.},
title = {ROS-Responsive Nanoparticles in Breast Cancer: Therapeutic Redox Manipulation and Toxicological Challenges},
journal = {Current Opinion in Toxicology},
year = {2026},
pages = {100629},
doi = {10.1016/j.cotox.2026.100629}
}
EUVIMED